Advent of 3D/4D Imaging to Revolutionize Cardiac Imaging, Catapulting Transesophageal Echocardiography Market Growth Prospects

Heightening demand for precision based imaging technologies with the objective of disbursing accurate treatment to patients is anticipated to open revenue frontiers for TEE manufacturers in the short and long run forecast period

Fact.MR, Rockville MD: The global transesophageal echocardiography (TEE) market is expected to witness credible gains through 2021, concludes an ongoing research study by awarding winning market research company Fact.MR. According to Fact.MR’s report, prolific advancements in healthcare infrastructure, combined with incorporation of advanced imaging techniques to facilitate superior diagnosis are likely to underpin growth.

The global burden of heart disease has compounded over the past few years, with cardiovascular disease (CVD) - including ischemic heart disease and stroke- being the major culprit. Cases have nearly doubled- from 271 million in 1990 to 523 million in 2019, with the death toll increasing to nearly 19 million. Furthermore, according to the Centers for Disease Control and Prevention, heart disease is the leading cause of death across the US, with at least one fatality every 36 seconds, and cost over US$ 200 billion to the economy each year.

Therefore, healthcare equipment manufacturers are leaving no stone unturned to ensure that healthcare providers have access to the best equipment. Key service providers are effectively integrating 3-dimensional and 4-dimensional imaging technologies to better assist clinicians in administering high-grade treatment. For instance, Enverdis® offers it’s CARDIOLOGIC EXPLORER (CAE), a broad, non-invasive and fast diagnosis of the heart, incorporating 3D ECG/cardiogoniometry for addressing patients suffering from acute coronary heart disease. The module also offers high ergometry and a chest pain explorer for early diagnosis of acute patients.

“As medical infrastructure worldwide improves, healthcare providers are incorporating every possible technological advancement to offer state-of-the-art care to patients, with prolific expansion opportunities in store for the cardiovascular disease segment. Hence, an upswing in TEE sales is anticipated in forthcoming years,” says the Fact.MR analyst.   

Request a report sample to gain comprehensive insights at

Key Takeaways from Fact.MR’s Transesophageal Echocardiography (TEE) Market Study

  • Demand for 3D and 4D TEE devices is expected to experience a massive incline
  • Heart valve disease treatment to make maximum utilization of TEE devices in upcoming years
  • Hospitals & Diagnostic Centers to be the primary TEE devices end-users
  • US to witness inclining sales, attributed to rising preference for precision based treatment
  • Extensive applications to treat CVDs heightening sales prospects across the UK
  • Germany and France to generate multiple revenue pools for key TEE device manufacturers
  • Rapid advancements in healthcare infrastructure development to widen sales prospects across India

Transesophageal Echocardiography (TEE) Market- Prominent Drivers

  • Growing expenditure to streamline healthcare infrastructure is bolstering TEE devices uptake across key regions
  • Breakthroughs in medical imaging technologies are providing fertile ground for enhanced sales
  • Increased prevalence of coronary heart disease is acting as a major growth lever for the market

Transesophageal Echocardiography (TEE) Market- Key Restraints

  • High installation costs of TEE devices are likely to restrict adoption to large-scale hospitals and diagnostic centers
  • Availability of alternative imaging technologies which are more efficient are restricting uptake

Discover more about the TEE market with figures and data tables, along with the table of contents. You will also find detailed market segmentation on

Competitive Landscape

Some prominent transesophageal echocardiography manufacturers profiled by Fact.MR’s market study include GE Healthcare, Philips Healthcare, Siemens Healthineers and Toshiba Medical Systems Corporation. The aforementioned manufacturers have adopted a slew of expansion strategies, including new equipment launches and collaborations with small-scale manufacturers to expand their footprint.

In 2017, Siemens Healthineers unveiled its 3D TEE Imaging Support System for assisting in surgical procedures for left atrial appendage closures. Left atrial appendage is a surgical procedure highly recommended for patients who are anticoagulant intolerant. Siemens’s WATCHMAN and Amulet devices have been effectively leveraged to provide enhanced 2D and 3D TEE techniques to heart surgeons.

 More Insights on the Transesophageal Echocardiography (TEE) Market

Fact.MR, in its new offering, brings to fore an unbiased analysis of the global transesophageal echocardiography (TEE) market, presenting historical demand data (2016-2020) and forecast statistics for the period, 2021-2031. The study divulges compelling insights on the market based on product type (two dimensional (2D), three dimensional (3D) and four dimensional (4D)), disease type (congenital heart disease, heart valve disease, coronary heart disease, blood vessel disease and others) and end-user (hospitals, ambulatory surgical centers, diagnostic centers, homecare settings and point of care) across seven major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain

Cattle Health Market: Explore Fact.MR’s ongoing cattle health market coverage and glean the latest insights on the key growth drivers anticipated to shape expansion trajectory for the forthcoming decade. The study has incorporated all essential elements, including a mapping of key segments across prominent geographical locations, as well as an incisive competitive landscape.

CHST15 Antibody Market: The global CHST15 antibody market study, in-progress by Fact.MR, elucidates on the key growth parameters for upcoming forecast period. The report sheds light on prominent expansion dynamics, including key market drivers, restraints and opportunities for the aforementioned time period. Additionally, a bird’s eye view of the market is also provided through such criteria as segmental analysis, regional profiling and competitive landscape.

Facial Bone Contouring Market: In its extensive study, Fact.MR elaborates on the major growth determinants which are likely to shape the future growth trajectory of the facial bone contouring market for the forthcoming forecast period. Facial bone contouring is a procedure performed to improve the bone structure of the face. The bone structure of the face should be improved so that it can have a better aesthetic appearance.   

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.    

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Follow Us: LinkedIn | Twitter
Market Intelligence Services:
Source: Fact.MR

Back to news